Circulating Tumour Cells (CTC) Trial
The National Institute of Integrative Medicine (NIIM) conducts the Circulating Tumour Cells (CTC) Test as part of a clinic study.
The study has been approved by an NHMRC registered ethics committee, and is registered on the Australia New Zealand Clinical Trial Registry.
The Circulating Tumour Cells (CTC) Trial is ongoing and the first published results are available at K Ried et al. Asian Pac J Cancer Prev 18 (8), 2275-2285. 2017 Aug 27
New Research article published in the Asian Pacific Journal of Cancer Prevention Screening for Circulating Tumour Cells Allows Early Detection of Cancer and Monitoring of Treatment Effectiveness: An Observational Study
What is Circulating Tumour Cell (CTC) analysis?
The ISET-CTC Test
- CTCs are Circulating Tumour Cells in the blood
- CTCs provide a biomarker for early cancer prognosis and treatment effectiveness
- The number of CTC or CTC count indicates the risk of malignancy or teh stage of cancer
- NIIM's CTC Analysis method is well established overseas and validated by substantial research
- In August 2017, NIIM has conducted over 1200 tests